recall
saveBreckenridge Pharmaceutical, Inc. recall (Cls II)
April 9, 2025updated 5mo ago
community read0 votes
Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx Only, 1,000 Capsules per bottle, Manufactured by: Towa Pharmaceutical Europe, S.L., Martorelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceutical, Inc., Berkley Heights, NJ 07922, NDC 51991-747-10. — Reason: CGMP Deviations: presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the recommended interim limit. — Status: Ongoing
view source ↗Data sources
last refreshed 42m ago
Found something off?
same company · ±60 days · 5
- recallBreckenridge Pharmaceutical, Inc recall (Cls II)Apr 30, 2025
- recallBreckenridge Pharmaceutical, Inc. recall (Cls II)Mar 19, 2025
- recallBreckenridge Pharmaceutical, Inc. recall (Cls II)Mar 19, 2025
- recallBreckenridge Pharmaceutical, Inc recall (Cls II)Apr 30, 2025
- recallBreckenridge Pharmaceutical, Inc. recall (Cls II)Mar 19, 2025
comments(0)
5-min edit window · permanent after that